4 September 2018 - Highest protein and lowest glucose formulation among parenteral nutrition products (with or without electrolytes) available in a standardised, triple-chamber bag.

Baxter Canada, a leader in nutrition therapy, today announced Health Canada approval of Olimel 7.6% and Olimel 7.6% E (amino acids, dextrose, lipids with/without electrolytes, injectable emulsion) for parenteral nutrition for adults when oral or enteral nutrition is impossible, insufficient or contra-indicated. 

These Olimel 7.6% nutrition solutions are the latest additions to the company's olive oil-based parenteral nutrition portfolio. As a ready-to-use solution, Olimel 7.6% (with or without electrolytes) is designed to meet the needs of high-risk patients by combining the highest protein with the lowest glucose formulation available in a standardised, triple-chamber bag.

Read Baxter press release